Items where Author is "Paréj, Katalin"

Article

Balogh, Andrea and Tóth, Eszter and Romero, Roberto and Paréj, Katalin and Csala, Diana and Kovács, Árpád Ferenc and Hupuczi, Petronella and Závodszky, Péter and Matkó, János and Papp, Zoltán and Pállinger, Éva and Than, Nándor Gábor (2019) Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response. FRONTIERS IN IMMUNOLOGY, 10. ISSN 1664-3224

Somogyi, Márk and Szimler, Tamás and Baksa, Attila and Végh, Barbara M. and Bakos, Tamás and Paréj, Katalin and Ádám, Csaba and Zsigmond, Áron and Megyeri, Márton and Flachner, Beáta and Sajó, Ráchel and Gráczer, Éva and Závodszky, Péter and Hajdú, István and Beinrohr, László (2019) A versatile modular vector set for optimizing protein expression among bacterial, yeast, insect and mammalian hosts. PLOS ONE, 14 (12). pp. 1-17. ISSN 1932-6203

Paréj, Katalin and Kocsis, Andrea and Enyingi, Csenge and Dani, Ráhel and Oroszlán, Gábor and Beinrohr, László and Dobó, József and Závodszky, Péter and Pál, Gábor and Gál, Péter (2018) Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway Activation. JOURNAL OF IMMUNOLOGY, 200 (7). pp. 2247-2252. ISSN 0022-1767

Paréj, Katalin and Hermann, Ágnes and Donáth, Nóra and Závodszky, Péter and Gál, Péter and Dobó, József (2014) Dissociation and re-association studies on the interaction domains of mannan-binding lectin (MBL)-associated serine proteases, MASP-1 and MASP-2, provide evidence for heterodimer formation. MOLECULAR IMMUNOLOGY, 59 (1). pp. 1-9. ISSN 0161-5890

Sándor, Noémi and Kristóf, Katalin and Paréj, Katalin and Pap, Domonkos and Erdei, Anna and Bajtay, Zsuzsanna (2013) CR3 is the dominant phagocytotic complement receptor on human dendritic cells. IMMUNOBIOLOGY, 218 (4). pp. 652-663. ISSN 0171-2985

Paréj, Katalin and Dobó, József and Závodszky, Péter and Gál, Péter (2013) The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not. Molecular immunology, 54. pp. 415-422. ISSN 1872-9142